top of page

Syndyma 400 mg Injection

SKU Cipla Ltd
असली कीमत

$1,333.01

बिक्री मूल्य

$959.77

Syndyma 400 mg Injection is a targeted anti-cancer therapy designed to combat various malignancies, including colon cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This innovative treatment contains bevacizumab, a monoclonal antibody that specifically inhibits vascular endothelial growth factor (VEGF), a protein that plays a crucial role in tumor growth by promoting blood vessel formation. By blocking VEGF, Syndyma helps to disrupt the blood supply to tumors, thereby slowing their progression and enhancing the effectiveness of other cancer therapies. Patients receiving this injection should be aware of potential side effects, including hypertension, bleeding complications, and an increased risk of infection. Regular monitoring and consultation with a healthcare provider are essential to ensure safe and effective treatment. Syndyma is administered intravenously and should only be used under the guidance of an oncologist. As part of a comprehensive cancer treatment plan, Syndyma 400 mg Injection offers hope for improved outcomes in individuals facing challenging diagnoses. Always discuss with your healthcare team about any concerns or questions regarding this therapy.

मात्रा

Active Pharmaceutical Ingredient

Bevacizumab 400 mg

Uses

• Syndyma 400 mg injection is utilized in the treatment of colorectal cancer, which affects the colon and rectum. This medication helps manage symptoms such as changes in bowel habits, including diarrhea and constipation. Patients may also experience abdominal pain and unintended weight loss, which Syndyma aims to alleviate. By targeting cancerous cells, Syndyma 400 mg injection supports improved patient outcomes.
• Non-small cell lung cancer is another condition treated with Syndyma 400 mg injection. This type of lung cancer can lead to persistent coughing and chest discomfort, impacting the patient's quality of life. By administering Syndyma, healthcare providers aim to reduce these symptoms and improve lung function. The injection plays a crucial role in the overall management of this challenging disease.
• Syndyma 400 mg injection is effective in the management of glioblastoma, a serious form of brain cancer. Patients suffering from this condition may experience severe headaches and cognitive changes, making timely treatment essential. The administration of Syndyma helps to target the aggressive nature of glioblastoma, aiming to stabilize the disease and enhance patient well-being. This approach allows for better management of symptoms associated with brain tumors.
• In the case of kidney cancer, Syndyma 400 mg injection is an important treatment option. This type of cancer often presents with symptoms such as blood in the urine and pain in the back or side. By using Syndyma, oncologists strive to reduce tumor burden and improve overall kidney function. The injection is a vital component in the therapeutic strategy for patients facing kidney cancer.

Benefits

Syndyma 400 mg Injection can help to slow or stop the growth of cancer cells, which may lead to a reduction in the size of tumors or the spread of cancer to other parts of the body. Syndyma 16 ml Injection may help to reduce the risk of cancer progressing, which may improve the chances of successful long-term treatment outcomes. In some studies, Syndyma 400 mg has been shown to improve survival rates in people with certain types of cancer, including colorectal, ovarian, and lung cancer.

Side Effects

Like all medications, Syndyma Bevacizumab 400 mg can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Most Common Side Effects

• Body Weakness
• Constipation
• Loss of Appetite
• Speech Change
• Nausea
• Diarrhoea

Common Side Effects

• Allergic Reactions
• Delay in Wound Healing
• Change in Vision
• Headache
• High Blood Pressure

How To Use

Syndyma 400 mg Injection is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of Syndyma 400 mg will depend on the clinical condition of the patient's age and medical history and other factors. It is important to follow your doctor's instructions carefully when using this Syndyma 16 ml Injection.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Anti-cancer Injection Syndyma. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Anti-cancer Injection Syndyma and report any unusual symptoms or changes in kidney function to their physician. The dose of Syndyma Bevacizumab 400 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Syndyma Bevacizumab 400 mg. Syndyma 400 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Bevacizumab Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Bevacizumab Injection if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Syndyma 400 mg may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Injection Syndyma during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Syndyma 400 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Syndyma 16 ml Injection.

bottom of page